Cardiovascular Report Winter 2019

Cardiovascular Report (logo)

News for Physicians from Johns Hopkins Medicine

TAVR at Johns Hopkins

Originally intended for high-risk patients, TAVR is now being offered to low-risk ones as part of a national clinical trial that includes Johns Hopkins.

A photo shows the heart team.

Articles in this Issue